Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 58 citing articles:

Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies
Amira Mohammed Ali, Hiroshi Kunugi
Molecules (2021) Vol. 26, Iss. 5, pp. 1232-1232
Open Access | Times Cited: 116
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76
Applications of density functional theory in COVID-19 drug modeling
Naike Ye, Zekai Yang, Yuchen Liu
Drug Discovery Today (2021) Vol. 27, Iss. 5, pp. 1411-1419
Open Access | Times Cited: 59
Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential
Arafa Musa, Hamada S. Abulkhair, Ateyatallah Aljuhani, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 463-463
Open Access | Times Cited: 35
Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options
Mariem Znaidia, Caroline Demeret, Sylvie van der Werf, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1247-1247
Open Access | Times Cited: 36
Maize Flavonoid Biosynthesis, Regulation, and Human Health Relevance: A Review
Héctor A. Peniche‐Pavía, Tereso J. Guzmán, Jesús Miguel Magaña‐Cerino, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5166-5166
Open Access | Times Cited: 31
Food Plant Secondary Metabolites Antiviral Activity and Their Possible Roles in SARS-CoV-2 Treatment: An Overview
Deborah Giordano, Angelo Facchiano, Virginia Carbone
Molecules (2023) Vol. 28, Iss. 6, pp. 2470-2470
Open Access | Times Cited: 16
Targeting SARS-CoV-2 Non-Structural Proteins
W.G. Tam, Ana C. Lorenzo‐Leal, Luis R. Hernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 13002-13002
Open Access | Times Cited: 16
Phytochemicals for the treatment of COVID-19
Erica Españo, Jiyeon Kim, Kiho Lee, et al.
The Journal of Microbiology (2021) Vol. 59, Iss. 11, pp. 959-977
Open Access | Times Cited: 32
Identification of Hypericin as a Candidate Repurposed Therapeutic Agent for COVID-19 and Its Potential Anti-SARS-CoV-2 Activity
Aline da Rocha Matos, Bráulia Costa Caetano, João Luiz de Almeida Filho, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 22
Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 10, pp. 100125-100125
Open Access | Times Cited: 14
Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets
Zhouman He, Jia Yuan, Yuanwen Zhang, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1186-1210
Open Access | Times Cited: 10
Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development
Wei Zhu, Zeenat A. Shyr, Donald C. Lo, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 378, Iss. 2, pp. 166-172
Open Access | Times Cited: 23
Anthocyanins as Immunomodulatory Dietary Supplements: A Nutraceutical Perspective and Micro-/Nano-Strategies for Enhanced Bioavailability
Thadiyan Parambil Ijinu, Lorenza Francesca De Lellis, Santny Shanmugarama, et al.
Nutrients (2023) Vol. 15, Iss. 19, pp. 4152-4152
Open Access | Times Cited: 9
Promising phytochemicals of traditional Himalayan medicinal plants against putative replication and transmission targets of SARS-CoV-2 by computational investigation
Jagadish Natesh, Priya Mondal, Bhavjot Kaur, et al.
Computers in Biology and Medicine (2021) Vol. 133, pp. 104383-104383
Open Access | Times Cited: 20
Computational modeling predicts potential effects of the herbal infusion “horchata” against COVID-19
Eduardo Tejera, Yunierkis Pérez‐Castillo, G. Toscano, et al.
Food Chemistry (2021) Vol. 366, pp. 130589-130589
Open Access | Times Cited: 20
Probing the formation, structure and free energy relationships of M protein dimers of SARS-CoV-2
Yipeng Cao, Rui Yang, Wei Wang, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 573-582
Open Access | Times Cited: 15
In silico study of potential antiviral activity of copper(II) complexes with non–steroidal anti–inflammatory drugs on various SARS–CoV–2 target proteins
Elena Geromichalou, Dimitrios T. Trafalis, Panagiotis Dalezis, et al.
Journal of Inorganic Biochemistry (2022) Vol. 231, pp. 111805-111805
Open Access | Times Cited: 15
Algal Metabolites Can Be an Immune Booster against COVID-19 Pandemic
Ajay Kumar, Rahul Singh, Indrajeet Kumar, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 452-452
Open Access | Times Cited: 14
Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
Hong Zhou, Wei‐Jian Ni, Wei Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease
Kamonpan Sanachai, Panupong Mahalapbutr, Vannajan Sanghiran Lee, et al.
The Journal of Physical Chemistry B (2021) Vol. 125, Iss. 50, pp. 13644-13656
Closed Access | Times Cited: 19
Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease
Jawaria Jabeen, Nabeel Ahmed, Zunaira Shahzad, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 510-540
Open Access | Times Cited: 1
Exploring Niclosamide as a Multi-target Drug Against SARS-CoV-2: Molecular Dynamics Simulation Studies on Host and Viral Proteins
Prachi Jagtap, Virendra Kumar Meena, Susmit B. Sambhare, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 1
Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and in vitro activity inhibition
Julia Liang, Eleni Pitsillou, Katherine Ververis, et al.
Chemical Physics Letters (2021) Vol. 788, pp. 139294-139294
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top